Acenocoumarol
Showing 1 - 25 of 64
Venous Thromboembolism, Anticoagulant-induced Bleeding, Venous Thromboses Trial in Metepec (Rivaroxaban 20 MG [Xarelto], Aspirin
Completed
- Venous Thromboembolism
- +3 more
- Rivaroxaban 20 MG [Xarelto]
- +2 more
-
Metepec, Estado De Mexico, MexicoInstituto Mexicano Del Seguro Social
Aug 24, 2022
Pulmonary Hypertension
Recruiting
- Pulmonary Arterial Hypertension
- Oral anticoagulant treatment
-
Clermont-Ferrand, France
- +3 more
Mar 16, 2022
Real Life of New Oral Anticoagulants and Vitamin K Antagonists
Completed
- Atrial Fibrillation
- Direct oral antocoagulant: dabigatran, rivaroxaban, apixaban
- Vitamin K antagonist: warfarin, fluindione, acenocoumarol
-
Paris, FranceAssistance Publique Hôpitaux de Paris
Mar 28, 2022
Anticoagulant, Pharmacogenetics, Community Pharmacy Services Trial in Zaragoza (acenocoumarol, control)
Completed
- Anticoagulant
- +4 more
- acenocoumarol
- control
-
Zaragoza, SpainCentro de Salud Arrabal
May 3, 2021
Burden of Ischemic Stroke and Intake of Oral Anticoagulants in
Completed
- Atrial Fibrillation
- Oral anticoagulant
-
Multiple Locations, United KingdomMany facilities
Apr 23, 2021
Antiphospholipid Syndrome, Arterial Thrombosis Trial in Buenos Aires, Córdoba, Hamilton (Dual antiplatelet therapy, Combined
Recruiting
- Antiphospholipid Syndrome
- Arterial Thrombosis
- Dual antiplatelet therapy
- +3 more
-
Buenos Aires, Ciudad Autónoma De Buenos Aires, Argentina
- +2 more
Dec 12, 2022
Cervical Artery Dissection Trial in Denmark, Germany, Switzerland (Acetylsalicylic acid, Vitamin K antagonist)
Completed
- Cervical Artery Dissection
- Acetylsalicylic acid
- Vitamin K antagonist
-
Copenhagen, Denmark
- +9 more
Jan 14, 2020
Intracranial Hemorrhages, Intracranial Hemorrhage, Hypertensive, Subarachnoid Hemorrhage Trial in United Kingdom (Apixaban,
Completed
- Intracranial Hemorrhages
- +8 more
- Apixaban
- +6 more
-
Edinburgh, Midlothian, United Kingdom
- +66 more
Mar 31, 2022
Intra-cardiac Thrombus, STEMI, Heart Failure Trial in France, Réunion (Vitamin K antagonist, Direct oral anticoagulant)
Not yet recruiting
- Intra-cardiac Thrombus
- +2 more
- Vitamin K antagonist
- Direct oral anticoagulant
-
Angers, France
- +33 more
Apr 11, 2023
Aortic Valve Disease, Aortic Valve Stenosis, Stroke Trial in Nieuwegein (Continuation of oral anticoagulants, Interruption of
Recruiting
- Aortic Valve Disease
- +6 more
- Continuation of oral anticoagulants
- Interruption of oral anticoagulants
-
Nieuwegein, Utrecht, NetherlandsSt. Antonius Ziekenhuis
Feb 8, 2022
Adverse Drug Reaction Trial in Worldwide (Pharmacogenomic testing)
Completed
- Adverse Drug Reaction
- Pharmacogenomic testing
-
Vienna, Austria
- +6 more
Apr 15, 2022
Portal Vein Thrombosis Trial in New Delhi (Enoxaparin with acenocoumarol, )
Withdrawn
- Portal Vein Thrombosis
- Enoxaparin with acenocoumarol
- placebo
-
New Delhi, Delhi, IndiaInstitute of Liver and Biliary Sciences.
Jun 2, 2018
Pacemaker, Implantable Cardioverter-defibrillator Trial in Patra (Ultrasound-guided axillary venous access, Cephalic venous
Recruiting
- Pacemaker
- Implantable Cardioverter-defibrillator
- Ultrasound-guided axillary venous access
- Cephalic venous access
-
Patra, Rion, GreeceUniversity Hospital of Patras
Jul 9, 2021
Deep Vein Thrombosis, Pulmonary Embolism Trial in Bologna (Vitamin K antagonist (Coumarin anticoagulants))
Completed
- Deep Vein Thrombosis
- Pulmonary Embolism
- Vitamin K antagonist (Coumarin anticoagulants)
-
Bologna, BO, ItalyDept. of Angiology & Blood Coagulation, University Hospital S. O
Mar 18, 2021
Potential Adverse Outcomes in Routine Clinical Pratice
Completed
- Venous Thrombosis
- +3 more
- Rivaroxoban (Xarelto, Bay59-7939)
- Standard of care
-
Multiple Locations, Netherlands(unnamed)
Sep 22, 2021
Oral Surgery in Patients Taking Direct Oral Anticoagulants
Completed
- Anticoagulants and Bleeding Disorders
- +3 more
- Oral surgical procedure followed by local hemostatic measures (insertion of gelatine sponge and wound suturing)
-
Novi Sad, Vojvodina, SerbiaDental Clinic of Vojvodina
Aug 10, 2020
![](/image/sponsor/university_of_campania_"luigi_vanvitelli")
Anticoagulants and Bleeding Disorders, Atrial Fibrillation Trial in Naples
Recruiting
- Anticoagulants and Bleeding Disorders
- Atrial Fibrillation
-
Naples, ItalyUniversity of Campania "Luigi Vanvitelli"
Jun 10, 2020
Developing Anticoagulation Self-Report Measure in Adults
Not yet recruiting
- Adults Undergoing Oral Anticoagulation Therapy
- Participation in an web-based survey
-
San Donato Milanese, Milano, ItalyIRCCS Policlinico San Donato
Jul 26, 2023
Unsuspected Pulmonary Embolism in Cancer Patients
Completed
- Unsuspected Pulmonary Embolism
- Heparin, fondaparinux, vitamin-K antagonists, aspirin
-
Washington, District of Columbia
- +45 more
Aug 7, 2019
Observes Usage of Non-vitamin K Antagonist Oral Anticoagulants
Completed
- Atrial Fibrillation
- Non-vitamin K antagonist oral anticoagulant
-
Alcorcón, Madrid, Spain
- +44 more
Sep 2, 2021
Early Phase of Stroke. New Neuroimaging Markers and Biomarkers
Unknown status
- Cardioembolic Stroke
- Dabigatran
- Acenocoumarol
-
Terrassa, Barcelona, SpainHospital Universitari Mutua Terrassa
Mar 19, 2018
Atrial Fibrillation Trial in Worldwide (Edoxaban, VKA-Based Regimen)
Time at ED of Patients Wih Head Injury
Unknown status
- Head Injury Other
- +2 more
- Observation
-
San Lorenzo de El Escorial, Madrid, SpainHospital EL Escorial
May 30, 2019
Stroke Prevention In Atrial Fibrillation (Spaf)
Completed
- Atrial Fibrillation
- apixaban
- +3 more
-
Barcelona, Cataluña, SpainIDIAP Jordi Gol
Jan 15, 2019
Vaso-occlusive Crisis, Reduction in Hospitalizations, Sickle Cell Disease Trial in Durham (Apixaban, Placebo)
Terminated
- Vaso-occlusive Crisis
- +2 more
- Apixaban
- Placebo
-
Durham, North CarolinaDuke University Medical Center
Feb 27, 2020